Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic Arthritis
Enrolling by invitation · Phase 3
Conditions studied: Juvenile Idiopathic Arthritis
In brief
This open labelled randomized controlled trial will be carried out at the University of Child Health and the Children's Hospital, Lahore consisting of 6 months . In total 60 patients (30 in each group) fulfilling the inclusion criteria will be selected and enrolled in this study. Patients will be divided into two groups; Group A (Injection Etanercept+ Tab methotrexate) and Group B (Injection Etanercept+ Tab methotrexate). Data will be collected at baseline, 1,3 and 6 months. Data will be collected and recorded
Key facts
- Study ID
- NCT07386587
- Run by
- University of Child Health Sciences and Children's Hospital, Lahore
- People needed
- 60
- Starts
- 2026-01-27
- Expected to finish
- 2026-07-27
- Last updated by the study team
- 2026-02-04
Who can join
Age: 2 and older, up to 16. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Polyarticular JIA patients aged 2-16years Male or female patients Newly diagnosed patients
You may not qualify if…
- Other type of JIA including systemic-onset JIA, psoriatic arthritis, enthesitis-related arthritis, and oligoarticular arthritis Chronic or acute infection or severe infection episodes that required hospitalization or intravenous administration of antibiotics 30 days prior to study initiation A previous history of malignancy Active tuberculosis or any opportunistic infection, including herpes zoster Hepatitis B Positive patients A history of any chronic disease (except for JIA) that could influence the effectiveness or safety of the investigational medicinal product in investigator's opinion
Where it is running
- University of Child Health Sciences Lahore, The Children's hospital Lahore — Lahore, Punjab Province, Pakistan
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.